Expanded access programmes: patient interests versus clinical trial integrity

Paul Lorigan; Paolo A Ascierto; Reinhard Dummer; Alexander M Eggermont; Keith T Flaherty; Claus Garbe; Helen Gogas; Axel Hauschild; Richard F Kefford; John M Kirkwood; James Larkin; Georgina V Long; Michele Maio; Grant A McArthur; Antoni Ribas; Caroline Robert; Dirk Schadendorf; Vernon K Sondak; Jedd D Wolchok; Andrew M Hudson

doi:10.1016/S1470-2045(14)71161-1

Expanded access programmes: patient interests versus clinical trial integrity

Paul Lorigan, Paolo A Ascierto, Reinhard Dummer, Alexander M Eggermont, Keith T Flaherty, Claus Garbe, Helen Gogas, Axel Hauschild, Richard F Kefford, John M Kirkwood, James Larkin, Georgina V Long, Michele Maio, Grant A McArthur, Antoni Ribas, Caroline Robert, Dirk Schadendorf, Vernon K Sondak, Jedd D Wolchok, Andrew M Hudson

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	15-7
Number of pages	3
Journal	The Lancet Oncology
Volume	16
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(14)71161-1
Publication status	Published - Jan 2015

Keywords

Clinical Trials as Topic/ethics
Compassionate Use Trials/ethics
Health Services Accessibility/ethics
Humans
Patient Rights/ethics
Patient Safety
Risk Assessment
Risk Factors
Treatment Outcome

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

Access to Document

10.1016/S1470-2045(14)71161-1

Cite this

Lorigan, P., Ascierto, P. A., Dummer, R., Eggermont, A. M., Flaherty, K. T., Garbe, C., Gogas, H., Hauschild, A., Kefford, R. F., Kirkwood, J. M., Larkin, J., Long, G. V., Maio, M., McArthur, G. A., Ribas, A., Robert, C., Schadendorf, D., Sondak, V. K., Wolchok, J. D., & Hudson, A. M. (2015). Expanded access programmes: patient interests versus clinical trial integrity. The Lancet Oncology, 16(1), 15-7. https://doi.org/10.1016/S1470-2045(14)71161-1

@article{c66d6a01526d4c15a84449ff6a0df9af,

title = "Expanded access programmes: patient interests versus clinical trial integrity",

keywords = "Clinical Trials as Topic/ethics, Compassionate Use Trials/ethics, Health Services Accessibility/ethics, Humans, Patient Rights/ethics, Patient Safety, Risk Assessment, Risk Factors, Treatment Outcome",

author = "Paul Lorigan and Ascierto, {Paolo A} and Reinhard Dummer and Eggermont, {Alexander M} and Flaherty, {Keith T} and Claus Garbe and Helen Gogas and Axel Hauschild and Kefford, {Richard F} and Kirkwood, {John M} and James Larkin and Long, {Georgina V} and Michele Maio and McArthur, {Grant A} and Antoni Ribas and Caroline Robert and Dirk Schadendorf and Sondak, {Vernon K} and Wolchok, {Jedd D} and Hudson, {Andrew M}",

year = "2015",

month = jan,

doi = "10.1016/S1470-2045(14)71161-1",

language = "English",

volume = "16",

pages = "15--7",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier BV",

number = "1",

}

Lorigan, P, Ascierto, PA, Dummer, R, Eggermont, AM, Flaherty, KT, Garbe, C, Gogas, H, Hauschild, A, Kefford, RF, Kirkwood, JM, Larkin, J, Long, GV, Maio, M, McArthur, GA, Ribas, A, Robert, C, Schadendorf, D, Sondak, VK, Wolchok, JD & Hudson, AM 2015, 'Expanded access programmes: patient interests versus clinical trial integrity', The Lancet Oncology, vol. 16, no. 1, pp. 15-7. https://doi.org/10.1016/S1470-2045(14)71161-1

TY - JOUR

T1 - Expanded access programmes

T2 - patient interests versus clinical trial integrity

AU - Lorigan, Paul

AU - Ascierto, Paolo A

AU - Dummer, Reinhard

AU - Eggermont, Alexander M

AU - Flaherty, Keith T

AU - Garbe, Claus

AU - Gogas, Helen

AU - Hauschild, Axel

AU - Kefford, Richard F

AU - Kirkwood, John M

AU - Larkin, James

AU - Long, Georgina V

AU - Maio, Michele

AU - McArthur, Grant A

AU - Ribas, Antoni

AU - Robert, Caroline

AU - Schadendorf, Dirk

AU - Sondak, Vernon K

AU - Wolchok, Jedd D

AU - Hudson, Andrew M

PY - 2015/1

Y1 - 2015/1

KW - Clinical Trials as Topic/ethics

KW - Compassionate Use Trials/ethics

KW - Health Services Accessibility/ethics

KW - Humans

KW - Patient Rights/ethics

KW - Patient Safety

KW - Risk Assessment

KW - Risk Factors

KW - Treatment Outcome

U2 - 10.1016/S1470-2045(14)71161-1

DO - 10.1016/S1470-2045(14)71161-1

M3 - Article

C2 - 25638540

SN - 1470-2045

VL - 16

SP - 15

EP - 17

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 1

ER -